Literature DB >> 31877249

Characterizing Protein-Ligand Binding Using Atomistic Simulation and Machine Learning: Application to Drug Resistance in HIV-1 Protease.

Troy W Whitfield1,2, Debra A Ragland3, Konstantin B Zeldovich2, Celia A Schiffer3.   

Abstract

Over the past several decades, atomistic simulations of biomolecules, whether carried out using molecular dynamics or Monte Carlo techniques, have provided detailed insights into their function. Comparing the results of such simulations for a few closely related systems has guided our understanding of the mechanisms by which changes such as ligand binding or mutation can alter the function. The general problem of detecting and interpreting such mechanisms from simulations of many related systems, however, remains a challenge. This problem is addressed here by applying supervised and unsupervised machine learning techniques to a variety of thermodynamic observables extracted from molecular dynamics simulations of different systems. As an important test case, these methods are applied to understand the evasion by human immunodeficiency virus type-1 (HIV-1) protease of darunavir, a potent inhibitor to which resistance can develop via the simultaneous mutation of multiple amino acids. Complex mutational patterns have been observed among resistant strains, presenting a challenge to developing a mechanistic picture of resistance in the protease. In order to dissect these patterns and gain mechanistic insight into the role of specific mutations, molecular dynamics simulations were carried out on a collection of HIV-1 protease variants, chosen to include highly resistant strains and susceptible controls, in complex with darunavir. Using a machine learning approach that takes advantage of the hierarchical nature in the relationships among the sequence, structure, and function, an integrative analysis of these trajectories reveals key details of the resistance mechanism, including changes in the protein structure, hydrogen bonding, and protein-ligand contacts.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31877249      PMCID: PMC7771725          DOI: 10.1021/acs.jctc.9b00781

Source DB:  PubMed          Journal:  J Chem Theory Comput        ISSN: 1549-9618            Impact factor:   6.006


  74 in total

1.  Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1.

Authors:  M A Navia; P M Fitzgerald; B M McKeever; C T Leu; J C Heimbach; W K Herber; I S Sigal; P L Darke; J P Springer
Journal:  Nature       Date:  1989-02-16       Impact factor: 49.962

2.  The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP.

Authors:  Cai-Hong Yun; Kristen E Mengwasser; Angela V Toms; Michele S Woo; Heidi Greulich; Kwok-Kin Wong; Matthew Meyerson; Michael J Eck
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-28       Impact factor: 11.205

3.  Both a protective and a deleterious role for the L76V mutation.

Authors:  Alessandra Tartaglia; Annalisa Saracino; Laura Monno; Carmine Tinelli; Gioacchino Angarano
Journal:  Antimicrob Agents Chemother       Date:  2009-04       Impact factor: 5.191

Review 4.  Deep learning.

Authors:  Yann LeCun; Yoshua Bengio; Geoffrey Hinton
Journal:  Nature       Date:  2015-05-28       Impact factor: 49.962

5.  Time-lagged autoencoders: Deep learning of slow collective variables for molecular kinetics.

Authors:  Christoph Wehmeyer; Frank Noé
Journal:  J Chem Phys       Date:  2018-06-28       Impact factor: 3.488

6.  ID-Score: a new empirical scoring function based on a comprehensive set of descriptors related to protein-ligand interactions.

Authors:  Guo-Bo Li; Ling-Ling Yang; Wen-Jing Wang; Lin-Li Li; Sheng-Yong Yang
Journal:  J Chem Inf Model       Date:  2013-02-26       Impact factor: 4.956

7.  Elucidating the Interdependence of Drug Resistance from Combinations of Mutations.

Authors:  Debra A Ragland; Troy W Whitfield; Sook-Kyung Lee; Ronald Swanstrom; Konstantin B Zeldovich; Nese Kurt-Yilmaz; Celia A Schiffer
Journal:  J Chem Theory Comput       Date:  2017-10-09       Impact factor: 6.006

8.  How does a drug molecule find its target binding site?

Authors:  Yibing Shan; Eric T Kim; Michael P Eastwood; Ron O Dror; Markus A Seeliger; David E Shaw
Journal:  J Am Chem Soc       Date:  2011-05-13       Impact factor: 15.419

9.  Structure of HIV-1 protease in complex with potent inhibitor KNI-272 determined by high-resolution X-ray and neutron crystallography.

Authors:  Motoyasu Adachi; Takashi Ohhara; Kazuo Kurihara; Taro Tamada; Eijiro Honjo; Nobuo Okazaki; Shigeki Arai; Yoshinari Shoyama; Kaname Kimura; Hiroyoshi Matsumura; Shigeru Sugiyama; Hiroaki Adachi; Kazufumi Takano; Yusuke Mori; Koushi Hidaka; Tooru Kimura; Yoshio Hayashi; Yoshiaki Kiso; Ryota Kuroki
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-09       Impact factor: 11.205

10.  Structural and thermodynamic basis for the binding of TMC114, a next-generation human immunodeficiency virus type 1 protease inhibitor.

Authors:  Nancy M King; Moses Prabu-Jeyabalan; Ellen A Nalivaika; Piet Wigerinck; Marie-Pierre de Béthune; Celia A Schiffer
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

View more
  7 in total

1.  Deciphering Complex Mechanisms of Resistance and Loss of Potency through Coupled Molecular Dynamics and Machine Learning.

Authors:  Florian Leidner; Nese Kurt Yilmaz; Celia A Schiffer
Journal:  J Chem Theory Comput       Date:  2021-03-30       Impact factor: 6.006

Review 2.  Drug Design Strategies to Avoid Resistance in Direct-Acting Antivirals and Beyond.

Authors:  Ashley N Matthew; Florian Leidner; Gordon J Lockbaum; Mina Henes; Jacqueto Zephyr; Shurong Hou; Desaboini Nageswara Rao; Jennifer Timm; Linah N Rusere; Debra A Ragland; Janet L Paulsen; Kristina Prachanronarong; Djade I Soumana; Ellen A Nalivaika; Nese Kurt Yilmaz; Akbar Ali; Celia A Schiffer
Journal:  Chem Rev       Date:  2021-01-07       Impact factor: 60.622

3.  Drug Resistance Prediction Using Deep Learning Techniques on HIV-1 Sequence Data.

Authors:  Margaret C Steiner; Keylie M Gibson; Keith A Crandall
Journal:  Viruses       Date:  2020-05-19       Impact factor: 5.048

4.  Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188.

Authors:  Gordon J Lockbaum; Archie C Reyes; Jeong Min Lee; Ronak Tilvawala; Ellen A Nalivaika; Akbar Ali; Nese Kurt Yilmaz; Paul R Thompson; Celia A Schiffer
Journal:  Viruses       Date:  2021-01-25       Impact factor: 5.048

5.  Computing the Structural Dynamics of RVFV L Protein Domain in Aqueous Glycerol Solutions.

Authors:  Gideon K Gogovi; Swabir Silayi; Amarda Shehu
Journal:  Biomolecules       Date:  2021-09-29

6.  Non-active site mutants of HIV-1 protease influence resistance and sensitisation towards protease inhibitors.

Authors:  Tomas Bastys; Vytautas Gapsys; Hauke Walter; Eva Heger; Nadezhda T Doncheva; Rolf Kaiser; Bert L de Groot; Olga V Kalinina
Journal:  Retrovirology       Date:  2020-05-19       Impact factor: 4.602

7.  Ritonavir and xk263 Binding-Unbinding with HIV-1 Protease: Pathways, Energy and Comparison.

Authors:  Jianan Sun; Mark Anthony V Raymundo; Chia-En A Chang
Journal:  Life (Basel)       Date:  2022-01-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.